Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Other Non-Current Liabilities (2016 - 2025)

Mesa Laboratories' Other Non-Current Liabilities history spans 14 years, with the latest figure at $11.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 12.12% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $11.0 million, down 12.12%, while the annual FY2025 figure was $12.5 million, 20.12% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $11.0 million at Mesa Laboratories, down from $11.8 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $17.3 million in Q4 2023 and bottomed at $436000.0 in Q3 2021.
  • The 5-year median for Other Non-Current Liabilities is $8.0 million (2022), against an average of $8.7 million.
  • The largest annual shift saw Other Non-Current Liabilities plummeted 55.46% in 2021 before it surged 1465.6% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $8.3 million in 2021, then fell by 1.94% to $8.2 million in 2022, then surged by 111.94% to $17.3 million in 2023, then decreased by 27.99% to $12.5 million in 2024, then dropped by 12.12% to $11.0 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Other Non-Current Liabilities are $11.0 million (Q4 2025), $11.8 million (Q3 2025), and $12.7 million (Q2 2025).